Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAM-e Treatment of Depression in Parkinson's Disease
NCT00070941Phase 3Completed
- Sponsor
- NYU Langone Health
- Start
- Jul 2003
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of S-adenosylmethionine in major depressive disorder (MDD), sponsored by NYU Langone Health. Started Jul 2003; status: completed.
02
Drugs
S-adenosylmethionine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00070941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00070941.